Michio Painter
InvestorPartner at Ataraxia VC
Cambridge, Massachusetts
Writes $50K – $1M checks · typically $500K
Find your path to Michio
3 people in our graph can introduce you to Michio.
Each arrow is one introduction. Sign up to fill in the first one.
Ask Charles C Smith to introduce you to Michio
You →Charles · together at Ataraxia VC →Michio
Ask Jamie Chen to introduce you to Michio
You →Jamie · 2 people · together at Ataraxia VC →Michio
Sign up to find every way you can get introduced to Michio
- Your email: the people you already email who know Michio
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with Michio
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
About
Michio Painter leads the UMZH Translational Medicine Accelerator at Spark Zurich and serves as an investment manager for the UZH Life Sciences Fund. His background spans neuroscience, immunology, and aging research, with experience as a biotech founder and CEO at Blue Tx, a seed-stage investor at Ataraxia VC, and academic accelerator leadership at UZH. His work focuses on translating early-stage biotech technologies from laboratory settings toward clinical and commercial application.
Experience
- Translational Medicine Accelerator (TMA) / Spark ZurichHead of the UMZH Translational Medicine Acceleratorcurrent2022 — presentZurich, Switzerland
- UZH Life Sciences FundInvestment Manager and Board Secretarycurrent2022 — presentZurich, Switzerland
- Joyance PartnersChief Science Partner2021 — 2022Somerville, Massachusetts, United States
- Joyance PartnersInvestment Partner2020 — 2021Cambridge, Massachusetts, United States
- Joyance PartnersVenture Partner2019 — 2020Cambridge, MA
- Blue TherapeuticsCo-Founder & CEO2014 — 2020Cambridge, MA
- XPRIZE FoundationPrize Developer2016Los Angeles, CA
- Howard Hughes Medical Institute/Harvard UniversityPost-doctoral Research Fellow2014 — 2015Cambridge, Massachusetts, United States
- Harvard UniversityPhD Student2009 — 2014Boston, MA
- Harvard Medical SchoolResearch Assistant2007 — 2009Boston, MA
- hayden-harnettDirector of Operations2006 — 2007Brooklyn, New York
Skills & more
+1 more
Cell CultureLanguages French
From Michio's professional profile.
Investments
Investor
AOAFimmcyte
Per curated public sources.
Colleagues at Ataraxia VC
Frequently asked questions
- Who is Michio Painter?
- Michio Painter leads the UMZH Translational Medicine Accelerator at Spark Zurich and serves as an investment manager for the UZH Life Sciences Fund. His background spans neuroscience, immunology, and aging research, with experience as a biotech founder and CEO at Blue Tx, a seed-stage investor at Ataraxia VC, and academic accelerator leadership at UZH. His work focuses on translating early-stage biotech technologies from laboratory settings toward clinical and commercial application.
- Where does Michio Painter work?
- Michio Painter is Partner at Ataraxia VC.
- What check size does Michio Painter write?
- Michio Painter typically writes checks of $50K – $1M.
- What companies has Michio Painter invested in?
- Investments tracked here include AOA, Fimmcyte.
- Where did Michio Painter go to school?
- Michio Painter studied at Harvard University (PhD, Immunology); Middlebury College (BA, French).
Same school
Also attended Harvard University2,000
+ 1,994 more
Shared employers
Also worked at Joyance Partners33
+ 27 more
Also worked at XPRIZE Foundation48
+ 42 more
Also worked at Howard Hughes Medical Institute/Harvard University530
+ 524 more
Also worked at Harvard Medical School360
+ 354 more








































